drug-resistant Streptococcus pneumoniae

drug-resistant Streptococcus pneumoniae (DRSP)

a widespread strain of respiratory pathogen that is drug resistant. Until the 1960s S. pneumoniae was almost uniformly susceptible to penicillin alone. In 1967 resistance to penicillin and other microbial drugs was first reported in Australia. It has since spread worldwide. The introduction of pneumococcal conjugate vaccines has reduced the number of these infections substantially.
Mentioned in ?
References in periodicals archive ?
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System.
Outpatient fluoroquinolone therapy should be considered only for patients at increased risk for drug-resistant Streptococcus pneumoniae, including those with comorbid conditions such as diabetes, chronic inflammatory lung disease, liver or renal insufficiency, malignancy, or congestive heart failure, and for patients who have been treated recently with antibacterial agents, said Dr.
Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
What attacked this man so viciously was a strain of drug-resistant Streptococcus pneumoniae, among a growing number of super-bacteria that doctors said have baffled them by appearing across Los Angeles County in seemingly otherwise healthy people.
We've stopped treating some cases of otitis media due to the rising presence of drug-resistant Streptococcus pneumoniae," says Paradise.
Action plan for drug-resistant Streptococcus pneumoniae.
Bacteremic pneumonia caused by extensively drug-resistant Streptococcus pneumoniae.
Assessment of national reporting of drug-resistant Streptococcus pneumoniae United States, 1995-1996.
KETEK was designed to deliver an optimal spectrum of activity, with a short treatment duration, specifically for upper and lower respiratory tract infections, including those caused by drug-resistant Streptococcus pneumoniae pathogens.
Acute otitis media: Management and surveillance in an era of pneumococcal resistance--areport from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.